Evidence map›Paper›PMID 40480980›Full record

ArticleNature communications2025

TANGO2 binds crystallin alpha B and its loss causes desminopathy.

Maike Stentenbach, Laetitia A Hughes, Samuel V Fagan, Blake Payne, Danielle L Rudler, Stefan J Siira, Tim McCubbin, Anaëlle Chopin, Kara L Perks, Judith A Ermer and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Oligodendroglial TANGO2 Regulates Lipid Metabolism to Control Motor Coordination.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Maike StentenbachThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia.
Laetitia A HughesThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia.
Samuel V FaganThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia.ORCID http://orcid.org/0009-0002-3817-587X
Blake PayneThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia.
Danielle L RudlerThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia.
Stefan J SiiraThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia.ORCID http://orcid.org/0000-0002-8391-0143
Tim McCubbinAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, QLD, Australia.
Anaëlle ChopinThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia.
Kara L PerksThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia.
Judith A ErmerARC Centre of Excellence in Synthetic Biology, University of Western Australia, Crawley, WA, Australia.ORCID http://orcid.org/0000-0003-0234-9620
James HendryThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia.ORCID http://orcid.org/0000-0002-6988-1278
Teagan S ErSchool of Human Sciences, The University of Western Australia, Crawley, WA, Australia.
Shanti BalasubramaniamGenetic Metabolic Disorders Service, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Joel A EliadesDepartment of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia.
Livia C HoolSchool of Human Sciences, The University of Western Australia, Crawley, WA, Australia.ORCID http://orcid.org/0000-0001-7758-5252
Nicolle H PackerARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, NSW, Australia.
Edward S X MohARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, NSW, Australia.
Benjamin S PadmanThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia.
Oliver RackhamThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia. oliver.rackham@curtin.edu.au.ORCID http://orcid.org/0000-0002-5301-9624
Aleksandra FilipovskaThe Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia. aleksandra.filipovska@uwa.edu.au.ORCID http://orcid.org/0000-0002-6998-8403

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the TANGO2 gene cause an autosomal recessive disorder characterised by developmental delay, stress-induced episodic rhabdomyolysis, and cardiac arrhythmias along with severe metabolic crises. Although TANGO2 mutations result in a well characterised disease pathology, the function of TANGO2 is still unknown. To investigate the function of TANGO2, we knocked out the TANGO2 gene in human cells and mice. We identify that loss of TANGO2 impairs intermediate filament structure, resulting in fragmented mitochondrial networks and formation of cup-like mitochondria. In male mice, loss of TANGO2 caused heart defects, reduced muscle function and glucose intolerance by remodelling of intermediate filaments, which altered the mitochondrial and cytoplasmic proteomes, N-glycosylation and nucleocytoplasmic O-GlcNAcylation. We identify that TANGO2 binds the small heat shock protein crystallin alpha B (CRYAB) to prevent the aggregation of the intermediate filament desmin and in the absence of TANGO2, mice develop desminopathy, which is consistent with features found in patients carrying mutations in either desmin or CRYAB.

Indexed as

alpha-Crystallin B ChainDesminAnimalsCardiomyopathiesFemaleGlycosylationHumansIntermediate FilamentsMaleMiceMice, KnockoutMitochondriaMuscular DystrophiesMutationProtein Bindingalpha-Crystallin B ChainDesmin

Identifiers

PMID40480980
PMCPMC12144310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.